NCT07045272

Brief Summary

This study applied digital technology to a comprehensive lifestyle intervention strategy to design a digital behavioural intervention programme suitable for weight reduction in overweight obese infertile patients in China, and assessed its intervention effect through a randomised controlled trial.The main questions it aims to answer are: 1\) Design and implement a digital behavioural weight loss intervention programme; 2) Evaluate the impact of digital behavioural interventions on weight loss outcomes and health outcomes. Participants will be randomly assigned to a control group and an intervention group. The control group will receive only routine health education and the intervention group will receive an 8-week digital behavioural intervention. At the end of the intervention, the follow-up period will be one year for reproductive outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
15mo left

Started Jul 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jul 2025Aug 2027

First Submitted

Initial submission to the registry

June 9, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 1, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

July 10, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2027

Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

1.1 years

First QC Date

June 9, 2025

Last Update Submit

June 21, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Weight change

    From enrollment to the end of treatment at 8 weeks

  • Number of oocytes retrieved

    up to 16weeks

  • Number of embryos available for transfer

    up to 17 weeks

Secondary Outcomes (4)

  • Percentage of weight loss

    From enrollment to the end of treatment at 8 weeks

  • Body fat content and distribution

    From enrollment to the end of treatment at 8 weeks

  • live birth rate

    2 years

  • Pregnancy rate

    up to 1 year

Study Arms (2)

digital behavioral intervention

EXPERIMENTAL

A comprehensive intervention program that combines digital technologies,Including interventions for diet, exercise, mood, sleep, etc.

Behavioral: Experimental

Regular Education Group

NO INTERVENTION

Physicians provided only their standard verbal counseling during clinic visits, without any additional interventions.

Interventions

ExperimentalBEHAVIORAL

The intervention team provides lifestyle guidance to the subjects according to the behavioural intervention programme, and the subjects record information on diet, exercise and weight on the platform on a daily basis. Subjects are required to learn relevant health education knowledge on the platform by themselves, and they can also exchange experience in the group and receive motivational counselling from the instructors.

digital behavioral intervention

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Fulfilling the World Health Organization diagnostic criteria for infertility, defined as failure to achieve or sustain a clinical pregnancy after ≥1 year of regular unprotected sexual intercourse among couples of reproductive age;
  • patients aged 20-40 years seeking assisted reproductive technology (ART) treatment;
  • Body mass index (BMI) \>=24 kg/m²;
  • Willingness to undergo randomization;
  • Absence of significant comorbidities (e.g., uncontrolled hypertension, diabetes mellitus, malignancies);
  • Commitment to participate in and complete the intervention protocol.

You may not qualify if:

  • History of major systemic diseases (e.g., cardiovascular disorders, chronic respiratory diseases) or psychiatric disorders (e.g., schizophrenia, major depressive disorder);
  • Current or prior participation in other clinical trials within the past 3 months;
  • Medical contraindications to physical exercise (e.g., severe osteoarthritis, uncontrolled arrhythmias);
  • Previous weight-loss interventions, including pharmacological therapy (e.g., orlistat, liraglutide) or bariatric surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 9, 2025

First Posted

July 1, 2025

Study Start

July 10, 2025

Primary Completion (Estimated)

August 20, 2026

Study Completion (Estimated)

August 20, 2027

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share